Qrons to Present at the RHK Capital 4th Annual Disruptive Growth Conference Hosted by ReedSmith Presentation on Thursday, September 5, 2019 at 9:00am EST NEW YORK, NY, Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Qrons Inc. (OTCQB: QRON), an emerging biotechnology company...

Qrons Selects PCG Advisory for Investor Relations and Strategic Communications as it Advances its Product Candidates NEW YORK, NY,, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTCQB: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for...

Qrons Announces Upgrade to OTCQB Market Trading Continues Under Ticker "QRON" NEW YORK, NY, Aug. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Qrons Inc. (OTCQB: QRON) an emerging biotechnology company developing advanced stem...

Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Markets Related Activities New York, NY, June 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the...

Qrons Appoints Dr. Motti Ratmansky as Special Advisor for IND & Clinical Trial Preparations New York, NY, May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions to...